Patents Assigned to Antibioticos S.A.
-
Patent number: 8313922Abstract: The present invention relates to an improved process for the production of Daptomycin by fermentation with Streptomyces roseosporus, in the presence of n-decanal or Cuphea oil as sources of the n-decanoyl side chain. These reagents allow to reduce toxicity effects on the bacteria and to avoid the use of solvents in the feeding solution.Type: GrantFiled: July 30, 2009Date of Patent: November 20, 2012Assignee: Antibioticos S.p.A.Inventors: Gianluca Bertetti, Antonella Malcangi, Roberto Muraca, Guido Trione, Alessia Rossi
-
Patent number: 8247426Abstract: Disclosed is a crystalline form of irinotecan hydrochloride (I) and processes for the preparation thereof from crude irinotecan hydrochloride or another polymorphic form of irinotecan. Said crystalline form is particularly suitable for industrial use, because it is easily filtered and possesses characteristics of high stability and purity.Type: GrantFiled: November 10, 2009Date of Patent: August 21, 2012Assignee: Antibioticos S.p.A.Inventors: Giovanni Pozzi, Paolo Ghetti, Gaetano Balsamo, Ettore Negri, Marco Alpegiani, Angelo Bedeschi, Roberta Pizzocaro
-
Publication number: 20100179180Abstract: Disclosed is a crystalline form of irinotecan hydrochloride (I) and processes for the preparation thereof from crude irinotecan hydrochloride or another polymorphic form of irinotecan. Said crystalline form is particularly suitable for industrial use, because it is easily filtered and possesses characteristics of high stability and purity.Type: ApplicationFiled: November 10, 2009Publication date: July 15, 2010Applicant: ANTIBIOTICOS S.p.A.Inventors: Giovanni POZZI, Paolo Ghetti, Gaetano Balsamo, Ettore Negri, Marco Alpegiani, Angelo Bedeschi, Roberta Pizzocaro
-
Publication number: 20100047873Abstract: The present invention relates to an improved process for the production of Daptomycin by fermentation with Streptomyces roseosporus, in the presence of n-decanal or Cuphea oil as sources of the n-decanoyl side chain. These reagents allow to reduce toxicity effects on the bacteria and to avoid the use of solvents in the feeding solution.Type: ApplicationFiled: July 30, 2009Publication date: February 25, 2010Applicant: ANTIBIOTICOS S.p.AInventors: Gianluca BERTETTI, Antonella Malcangi, Roberto Muraca, Guido Trione, Alessia Rossi
-
Publication number: 20090192184Abstract: The invention relates to two novel crystalline form of Topotecan hydrochloride (Ia) Herein referred to as forms ? and ?, characterized by high purity and whose preparation is advantageous from the industrial point of view. Form ? can be in fact conveniently prepared starting from 10-hydroxy-camptothecin, whereas form ? can be prepared starting from form ?.Type: ApplicationFiled: December 3, 2008Publication date: July 30, 2009Applicant: ANTIBIOTICOS S.p.A.Inventors: Giovanni Pozzi, Paolo Ghetti, Gaetano Balsamo, Ettore Negri, Andrea Mazzoni, Marco Alpegiani, Angelo Bedeschi, Roberta Pizzocaro
-
Publication number: 20090036672Abstract: Disclosed are salts of the general formula (I) wherein R1, R2 and B are as defined in the description and methods for the preparation thereof. These salts are useful intermediates for the preparation of cefdinir.Type: ApplicationFiled: July 29, 2008Publication date: February 5, 2009Applicant: ANTIBIOTICOS S.p.A.Inventors: Giovanni Pozzi, Patricio Martin Gomez, Marco Alpegiani, Walter Cabri
-
Patent number: 7405294Abstract: Disclosed are salts of the general formula (I) wherein R1, R2 and B are defined in the description. These salts are useful intermediates for the preparation of cefdinir. Also, disclosed are processes for the preparation thereof from the compounds of the general formula (II) and (III). Further, disclosed is a method of producing cefdinir from the salts of the general formula (I) including the steps of removing protecting groups.Type: GrantFiled: September 26, 2003Date of Patent: July 29, 2008Assignee: Antibioticos S.p.A.Inventors: Giovanni Pozzi, Patricio Martin Gomez, Marco Alpegiani, Walter Cabri
-
Patent number: 7399624Abstract: Enzymes with cephalosporin C acylase activity obtained by site-directed, random or “site-saturation” mutagenesis of a native sequence optimised for expression in E. coli.Type: GrantFiled: January 11, 2005Date of Patent: July 15, 2008Assignee: Antibioticos S.p.A.Inventors: Loredano Pollegioni, Mirella Pilone, Gianluca Molla, Eugenio Cucchetti, Roberto Verga, Walter Cabri
-
Publication number: 20080160586Abstract: A process for the purification and recovery of Tacrolimus (I) (17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methyvinyl]-23,25- dimethoxy-13,19,21,27-tetramethyl-11,28-dioxi-4-azatricyclo-[22.3.1.04.9]octacos-18-en-2,3,10,16-tetraone), starting from Streptomyces sp fermentation broth. The process is particularly advantageous in terms of productivity and selectivity of the separation of impurities.Type: ApplicationFiled: October 24, 2005Publication date: July 3, 2008Applicant: Antibioticos S.p.A.Inventors: Walter Cabri, Paolo Paissoni, Jacopo Roletto, Luca Morra
-
Publication number: 20080161555Abstract: The invention relates to a process for the purification of tacrolimus comprising contacting crude tacrolimus with a silver salt dissolved in a water/organic solvent mixture and with a carrier of vegetable origin, separating the mixture from the carrier and recovering purified tacrolimus.Type: ApplicationFiled: July 10, 2006Publication date: July 3, 2008Applicant: ANTIBIOTICOS S.p.A.Inventors: Luca Morra, Jacopo Roletto, Giovanni Lazzari, Walter Cabri, Paolo Paissoni
-
Publication number: 20080076915Abstract: A process for the epoxidation of 17-oxo-15,16-methylene steroids, in particular of drospirenone precursors, comprising the use of sulfoxonium ylides, in particular of dimethylsulfoxonium methyl ylide. The process allows to prepare in good yields 17-spiro epoxides, which can be easily transformed into 17-spironolacto-steroids.Type: ApplicationFiled: September 21, 2007Publication date: March 27, 2008Applicant: ANTIBIOTICOS S.P.A.Inventors: Walter Cabri, Fabio Benedetti, Marco Alpegiani, Manuela Rodriquez, Cinzia Bottai
-
Patent number: 7252965Abstract: The invention consists of fermenting selected strains of Blakeslea trispora in conditions such that ?-carotene is produced in the form of stabilized preparations with residual contents of other carotenoids (?-carotene and ?-zeacarotene). The fermentation conditions chosen include the programmed addition of oxygen and/or ?-ionone during fermentation, and control of the age of the vegetative growth phases of the strains employed. The ?-carotene obtained can be used in the pharmaceutical and food sectors.Type: GrantFiled: January 23, 2003Date of Patent: August 7, 2007Assignee: Antibioticos, S.A.U.Inventors: Javier Costa Perez, Ana Teresa Marcos Rodríguez, Juan Luis De La Fuente Moreno, Marta Rodríguez Saiz, Bruno Diez Garcia, Enrique Peiro Cezon, Walter Cabri, José Luis Barredo Fuente
-
Patent number: 7173126Abstract: Cefdinir crystalline salts of formula (I), in which n ranges from 1 to 3, the preparation and use thereof for the preparation and purification of cefdinir are herein disclosed. The salts of formula (I) can be obtained from cefdinir intermediates or crude cefdinir by treatment with phosphoric acid.Type: GrantFiled: December 1, 2003Date of Patent: February 6, 2007Assignee: Antibioticos S.p.A.Inventors: Giovanni Pozzi, Patricio Martin Gomez, Marco Alpegiani, Walter Cabri
-
Publication number: 20060111566Abstract: Disclosed are salts of the general formula (I) wherein R1, R2 and as defined in the description and a process for the preparation thereof. These salts are useful intermediates for the preparation of cefdinir.Type: ApplicationFiled: September 26, 2003Publication date: May 25, 2006Applicant: Antibioticos S.p.A.Inventors: Giovanni Pozzi, Patricio Martinez Gomez, Marco Alpegiani, Walter Cabri
-
Publication number: 20060074236Abstract: Cefdinir crystalline salts of formula (I), in which n ranges from 1 to 3, the preparation and use thereof for the preparation and purification of cefdinir is herein disclosed. The salts of formula (I) can be obtained from cefdinir intermediates or crude cefdinir by treatement with phosphoric acid.Type: ApplicationFiled: December 1, 2003Publication date: April 6, 2006Applicant: ANTIBIOTICOS S.p.A.Inventors: Giovanni Pozzi, Patricio Martin Gomez, Marco Alpegiani, Walter Cabri
-
Patent number: 7019140Abstract: A process for the synthesis of pergolide (Formula (I)) (D-6-n-propyl-8?methylmercaptomethylergo line) from acid 9,10-dihydrolysergic is herein disclosed. The process can be carried out without isolating most intermediates and is particularly convenient both from the yield and safety standpoint.Type: GrantFiled: March 10, 2003Date of Patent: March 28, 2006Assignee: Antibioticos S.p.A.Inventors: Walter Cabri, Paolo Paissoni, Jacopo Roletto, Piera Fonte, Sara Olmo
-
Publication number: 20050272934Abstract: The invention relates to a process for the preparation of thalidomide (I) comprising the reaction between glutamine (II) and a phthaloylating agent, preferably phthalic anhydride, to give N-phthaloyl-glutamine, which is directly transformed in thalidomide.Type: ApplicationFiled: May 31, 2005Publication date: December 8, 2005Applicant: ANTIBIOTICOS S.p.A.Inventors: Marco Alpegiani, Andrea Mazzoni, Domenico Vergani, Walter Cabri
-
Publication number: 20050158818Abstract: Enzymes with cephalosporin C acylase activity obtained by site-directed, random or “site-saturation” mutagenesis of a native sequence optimised for expression in E. coli.Type: ApplicationFiled: January 11, 2005Publication date: July 21, 2005Applicant: ANTIBIOTICOS S.p.A.Inventors: Loredano Pollegioni, Mirella Pilone, Gianluca Molla, Eugenio Cucchetti, Roberto Verga, Walter Cabri
-
Patent number: 6844455Abstract: The present invention discloses a process for the semi-synthesis of 4-demethoxydaunomycinone, (8s-cis)-acetyl-10-hydroxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-5,12-naphthacenedione, of formula (I).Type: GrantFiled: May 10, 2001Date of Patent: January 18, 2005Assignee: Antibioticos S.p.A.Inventors: Valentina Pizzamiglio, Walter Cabri, Elio Mapelli
-
Patent number: 6642378Abstract: The invention is directed towards a process for the preparation of Cefuroxime acid or for a corresponding pharmaceutically acceptable salt or ester. The process comprises the carbamoylation of a Cefuroxime precursor with an activated isocyanate. Additionally, the process is characterized by the fact that a carbonic C1-C4 alkyl ester is used as a solvent for the carbamoylation reaction.Type: GrantFiled: March 13, 2002Date of Patent: November 4, 2003Assignee: Antibioticos S.p.A.Inventors: Walter Cabri, Enrico Siviero, Paola Luigia Daverio, Tania Cristiano, Claudio Felisi, Davide Longoni